Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Alan Hb Wu"'
Autor:
Jinan Guo, Heather Johnson, Xuhui Zhang, Xiaoyan Feng, Heqiu Zhang, Athanasios Simoulis, Alan HB Wu, Taolin Xia, Fei Li, Wanlong Tan, Allan Johnson, Nishtman Dizeyi, Per‐Anders Abrahamsson, Lukas Kenner, Lingwu Chen, Wanmei Zhong, Kefeng Xiao, Jenny L. Persson, Chang Zou
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 3, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/fe8a11bc1fb44379b760e90d4e4b862c
Autor:
Dalga D Surofchy, PharmD (c), Sam Oh, PhD, MPH, Joshua Galanter, MD, MAS, Pin Xiang, PharmD, Megan Li, PhD (c), Su Guo, PhD, Tejal Desai, PhD, B Joseph Guglielmo, PharmD, Kathy Giacomini, PhD, Janel Long-Boyle, PharmD, PhD, Alan HB Wu, PhD, Esteban Burchard, MD, MPH
Publikováno v:
INNOVATIONS in Pharmacy, Vol 8, Iss 1 (2017)
Objective: To evaluate if pharmacy students’ participation in personal pharmacogenetic (Pgx) testing enhances their knowledge and attitude towards precision medicine (PM). Methods: First-year pharmacy students were offered personalized pharmacog
Externí odkaz:
https://doaj.org/article/e010c3244be1473dba8ffb56cc714c14
Autor:
Heather Johnson, Allan Johnson, Lingwu Chen, Xiaoyan Feng, Nishtman Dizeyi, Wanmei Zhong, Heqiu Zhang, Athanasios Simoulis, Lukas Kenner, Per-Anders Abrahamsson, Alan Hb Wu, Wanlong Tan, Fei Li, Xuhui Zhang, Taolin Xia, Kefeng Xiao, Jinan Guo, Chang Zou, Jenny L. Persson
Publikováno v:
Clinical and Translational Medicine
Clinical and Translational Medicine, Vol 11, Iss 3, Pp n/a-n/a (2021)
Clinical and Translational Medicine, Vol 11, Iss 3, Pp n/a-n/a (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::381202561108894355426b2831ea3604
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181936
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181936
Autor:
Jeffrey D. Whitman, Andrew G. Levine, Shannon A Kastner, Gregory M. Goldgof, Alan Hb Wu, Brian R. Shy, Jonathan H. Esensten, Erica W Beckerdite, Allen W. Hightower, Kara L. Lynch, Noreen P Lacanienta, Susan L. Stramer, Sagar P. Bapat, Caryn Bern
Publikováno v:
Clinical Infectious Diseases
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 72, iss 2
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 72, iss 2
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can be detected indirectly by measuring the host immune response. For some viruses, antibody concentrations correlate with host protection and viral neutralization, but
Autor:
Alan Hb Wu
Publikováno v:
Personalized Medicine. 15:149-151
Autor:
Mehrdad Arjomandi, Doris Vuong, Heng Yu, Alice Juang, Alan Hb Wu, Tess Rubenstein, Amanda L Fish, Michael Beggs, Abigail D. Rostykus, Luis Carbonell, Manpreet Sidhu, Sandy Kamer, Shan X. Wang, Bhavin Patel, James K. Brown, Neil N. Trivedi
Publikováno v:
Biomedical research and reviews, vol 2, iss 3
Biomedical research and reviews
Biomedical research and reviews
Author(s): Trivedi, Neil N; Brown, James K; Rubenstein, Tess; Rostykus, Abigail D; Fish, Amanda L; Yu, Heng; Carbonell, Luis; Juang, Alice; Kamer, Sandy; Patel, Bhavin; Sidhu, Manpreet; Vuong, Doris; Wang, Shan; Beggs, Mike; Wu, Alan Hb; Arjomandi, M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9e4ca4ea7002f2e6011849ca9f8590
https://escholarship.org/uc/item/85b823sg
https://escholarship.org/uc/item/85b823sg
Autor:
Mohan Kocherla, Golriz Yazdanpanah, Richard L. Seip, Jorge Duconge, Gualberto Ruaño, Alan Hb Wu, Andreas Windemuth, Theodore R. Holford, Bruce Bower, C Michael White, David Villagra, Paul D. Thompson
Publikováno v:
Personalized medicine. 5(3)
Background: Polymorphisms in the cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1) genes significantly alter the effective warfarin dose. The CYP2C9*2 (430C>T), CYP2C9*3 (1075A>C) and VKORC1 -1639 G>A polymorphis
Publikováno v:
Personalized medicine. 12(3)
Autor:
Alan Hb Wu
Publikováno v:
Personalized medicine. 14(1)
Autor:
Alan Hb Wu
Publikováno v:
Personalized medicine. 15(2)